# US 2013/0295647 A1 · Method of producing bacteriophage preparations comprising purification using affinity chromatography

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0295647 A1
- Document ID: US20130295647A1
- Status: Published application
- Kind: A1
- Application number: 13/881,795
- Filed: 2011-10-28
- Published: 2013-11-07
- Earliest claimed: 2010-10-28
- Assignees: Instytut Immunologii I Terapii Doswiadczalnej Pan
- Inventors: Krystyna Dabrowska; Anna Oslizlo; Paulina Budynek; Agnieszka Otrowicz; Andrzej Gorski; Grzegorz Figura; Barbara Owczarek; Agnieszka Kopciuch
- Web page: https://patentgrep.com/patent/US20130295647A1

## CPC

- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C07K 14/005: from viruses
- C07K 2319/21: containing a His-tag
- C07K 2319/23: containing a GST-tag
- C12N 2795/00051: Methods of production or purification of viral material
- C12N 2795/10122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2795/10151: Methods of production or purification of viral material
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The proposed method facilitates the single-stage and at the same time effective purification of phage preparations for therapeutic uses, and facilitates the maintenance of bacteriophage antibacterial activity both in the case of displacement of the bacteriophage from the resin and its proteolytic release. The protein modification of the phage capsid with appropriate binding motifs makes it possible to purify therapeutically bacteriophage strains using affinity chromatography. The proposed method is useful in the display of selected polypeptided on a bacteriophage capsid without the need to genetically modify the bacteriophage, and thus makes it possible to produce phage preparations for various uses using wild-type phages occurring naturally or others not additionally modified for phage-display purposes.

## Claims

### Claim 1

A method of producing bacteriophages, characterized in that:
a) a bacterial host strain is cultured on an appropriate medium, the culture is inoculated with a bacteriophage and a bacteriophage lysate is produced,
b) the lysate is purified using affinity chromatography,
d) the resulting filtrate is used to prepare a purified bacteriophage,
wherein in stage a) the bacterial host strain used consists of bacterial cells containing a sequence encoding a fusion protein containing a foreign polypeptide exhibiting an affinity for a chromatography resin used in stage b) and a polypeptide from among the structural phage proteins of the bacteriophage present in the resulting lysate.

### Claim 2 (depends on 1)

A method according to claim 1, characterized in that polypeptide exhibiting an affinity for a chromatography resin is selected from a group encompassing HisTag and GST.

### Claim 3 (depends on 1)

A method according to claim 1, characterized in that during stage a) the bacterial host strain culture is conducted on a culture broth with a pH of about 7.2 containing a meat extract, enzymatic casein hydrolysate, yeast hydrolysate, peptone and NaCl.

### Claim 4 (depends on 1)

A method according to claim 1, characterized in that during stage a) the bacterial host strain used us a bacterial strain sensitive to the lytic activity of the amplified bacteriophage.

### Claim 5 (depends on 1)

A method according to claim 1, characterized in that during stage a) the culture is inoculated with a bacteriophage strain not genetically modified in order to use the phage-display method.

### Claim 6 (depends on 1)

A method according to claim 1, characterized in that during stage a) the resulting phage lysate is filter-sterilized through a 0.22 μm sterilizing filter.
